What is the usual CW constraint for peripheral lung SBRT lesions?
For 3 fx lung SBRT
- V30 < 30 cc
Caveats:
- May not always be possible for peripheral lesions
- Do not compromise target coverage
- ASTRO guidelines explicitly forbid from trimming PTV to meet this CW constraint
- CW tox (pain, etc) is usually amenable to conservative management
What is the threshold for CW dose before Gr ≥ 2 CW tox is observed in lung SBRT pts>
What are the usual OAR constraints for lung SBRT?
What are the SRS Dmax constraints for the Optic nerve (ON)?
SRS constraints for ON:
- Dmax < 8 Gy
– Rare (~0%) risk of optic neuropathy
- Dmax < 12 Gy
– <10% risk of optic neuropathy
What are the NCCN dose constraints for the lungs for pts receiving CFRT for esophageal or gastric cancers?
Lung constraints for esophageal cancer CFRT?
- V40Gy ≤ 10%
- V30Gy ≤ 15%
- V20Gy ≤ 20%
- V10Gy ≤ 40%
- V5Gy ≤ 50%
- Dmean < 20 Gy
What are acceptable lung constraints for centrally located lesions undergoing 5 fx SBRT?
What are the NCCN dose constraints for the spine for pts receiving CFRT for esophageal or gastric cancers?
Spine constraints for esophageal cancer CFRT:
- Dmax ≤ 45 Gy
What are the NCCN dose constraints for the bowel for pts receiving CFRT for esophageal or gastric cancers?
Bowel constraints for esophageal cancer CFRT:
- Dmax < 54 Gy
- V 45Gy < 195 cc
What are the NCCN heart dose constraints for pts receiving CFRT for esophageal or gastric cancers?
Heart constraints for esophageal cancer CFRT:
- V30Gy ≤ 30 % (20% preferred)
- Dmean < 30 Gy (26 Gy preferred)
What are the NCCN stomach dose constraints for pts receiving CFRT for esophageal or gastric cancers?
Stomach constraints for esophageal cancer CFRT:
- Dmean < 45 Gy
- Dmax < 54 Gy
What are the NCCN liver dose constraints for pts receiving CFRT for esophageal or gastric cancers?
Liver constraints for esophageal cancer CFRT:
- V30Gy ≤ 33%
- Dmean < 25 Gy
What are the NCCN kidney dose constraints for pts receiving CFRT for esophageal or gastric cancers?
Kidney constraints for esophageal cancer CFRT:
- V20Gy ≤ 33%
- Dmean <18 Gy
– Corresponds to a <5% risk of relevant kidney dysfunction
For liver SBRT, what are the allowed Dmean for the liver?
Liver constraints for Lung SBRT:
- 50 Gy in 5 fx:
– Dmean < 13 Gy
- 27.5 Gy in 5 fx:
– Dmean < 17 Gy
What is the % risk of developing symptomatic pneumonitis when using the lung dose constraint (V20Gy < 30%)?
< 20%
What are the dose constraints for the cochlea for CFRT?
What are the dose constraints for the cochlea for SRS?
Dmax < 9 Gy
Dmean < 3 Gy
What are the QUANTAC rectal dose constraints to keep grade ≥2 late rectal toxicity < 15% and grade ≥3 late rectal toxicity < 10%?
Rectal Dose Constraints:
- V50Gy < 50%
- V60Gy < 35%
- V65Gy < 25% (65+25=90)
- V70Gy < 20% (70+20=90)
- V75Gy < 15% (75+15=90)
Rule of 90s for the three highest constraints!
Also, related to bladder constraints:
- V75 < 25%; Subtract 10% for rectum (V75 < 15%)
- V70 < 35%; Subtract 15% for rectum (V70 < 20%)
- V65 < 50%; Subtract 25% for rectum (V65 < 25%)
What are the QUANTAC bladder dose constraints for CFRT?
Bladder Dose Constraints:
- V65Gy < 50%
- V70Gy < 35%
- V75Gy < 25%
- V85Gy < 15%
Memory Hook:
- Bladder:
– V75 < 25%; Subtract 10% for rectum (V75 < 15%)
– V70 < 35%; Subtract 15% for rectum (V70 < 20%)
– V65 < 50%; Subtract 25% for rectum (V65 < 25%)
What is the SRS brainstem constraint to keep the risk of necrosis or cranial neuropathy < 5%?
SRS Brainstem constraint
- Dmax < 12.5 Gy
What are the QUANTAC pharyngeal constrictor dose constraint to keep the risk of dysphagia or symptomatic aspiration < 20%?
Dmean < 50 Gy
What is the QUANTAC penile bulb dose constraint to keep the risk of ED < 35%?
Which sites in an adult human body harbor bone marrow and in what proportions?
What were the trachea/bronchus constraints on the RTOG 0813 dose-escalation trial for centrally located NSCLC?
What duodenal, stomach, small blowel constraints can be used for pancreas SBRT?